WallStSmart

Diebold Nixdorf, Incorporated (DBD)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Diebold Nixdorf, Incorporated generates 63213% more annual revenue ($3.86B vs $6.09M). DBD leads profitability with a 2.8% profit margin vs 0.0%. DBD earns a higher WallStSmart Score of 56/100 (C).

DBD

Buy

56

out of 100

Grade: C

Growth: 7.0Profit: 5.5Value: 5.3Quality: 5.0

VUZI

Avoid

17

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DBD.

VUZIUndervalued (+40.5%)

Margin of Safety

+40.5%

Fair Value

$4.15

Current Price

$4.60

$0.45 discount

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DBD2 strengths · Avg: 9.0/10
EPS GrowthGrowth
815.0%10/10

Earnings expanding 815.0% YoY

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

DBD2 concerns · Avg: 3.5/10
P/E RatioValuation
28.0x4/10

Moderate valuation

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
15.3x4/10

Trading at 15.3x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$393.34M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : DBD

The strongest argument for DBD centers on EPS Growth, Price/Book.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : DBD

The primary concerns for DBD are P/E Ratio, Profit Margin. Thin 2.8% margins leave little buffer for downturns.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

VUZI carries more volatility with a beta of 1.52 — expect wider price swings.

DBD is growing revenue faster at 6.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DBD scores higher overall (56/100 vs 17/100). VUZI offers better value entry with a 40.5% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?